These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27266590)

  • 21. First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.
    Savini H; Bogreau H; Bertaux L; Bouchiba H; Kraemer P; Parzy D; Garnotel E; Rogier C; Simon F; Pradines B
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2283-4. PubMed ID: 18411319
    [No Abstract]   [Full Text] [Related]  

  • 22. Artemether-lumefantrine compared to atovaquone-proguanil as a treatment for uncomplicated Plasmodium falciparum malaria in travelers.
    Grynberg S; Lachish T; Kopel E; Meltzer E; Schwartz E
    Am J Trop Med Hyg; 2015 Jan; 92(1):13-7. PubMed ID: 25371188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acquisition of atovaquone-proguanil resistance in imported falciparum malaria in a young child].
    Aurégan C; Argy N; Hubert V; Aprahamian A; Clain J; Cheron G
    Presse Med; 2017 Mar; 46(3):344-346. PubMed ID: 28040348
    [No Abstract]   [Full Text] [Related]  

  • 24. Atovaquone-proguanil treatment failure in a case of pediatric Plasmodium falciparum infection: Malabsorption and resistance.
    L'Huillier AG; Lau R; Bitnun A; Boggild AK
    Travel Med Infect Dis; 2020; 37():101829. PubMed ID: 32763494
    [No Abstract]   [Full Text] [Related]  

  • 25. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanshard A; Hine P
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
    Khositnithikul R; Tan-Ariya P; Mungthin M
    Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fluindione and falciparum malaria treated by atovaquone-proguanil].
    Kamaliddin C; Joste V; Argy N; Houzé S
    Therapie; 2018 Oct; 73(5):445-447. PubMed ID: 29680373
    [No Abstract]   [Full Text] [Related]  

  • 29. Atovaquone/proguanil for plasmodium falciparum malaria.
    Sehdev PS
    Pediatr Infect Dis J; 2002 Aug; 21(8):787-9. PubMed ID: 12192170
    [No Abstract]   [Full Text] [Related]  

  • 30. Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.
    Cordel H; Cailhol J; Matheron S; Bloch M; Godineau N; Consigny PH; Gros H; Campa P; Bourée P; Fain O; Ralaimazava P; Bouchaud O
    Malar J; 2013 Nov; 12():399. PubMed ID: 24200190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.
    Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
    Staines HM; Burrow R; Teo BH; Chis Ster I; Kremsner PG; Krishna S
    J Antimicrob Chemother; 2018 Mar; 73(3):581-595. PubMed ID: 29237012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of malarone in therapy of malaria tropica].
    Ziegler T; Schau A; Winkler C
    Med Klin (Munich); 2002 Aug; 97(8):455-8. PubMed ID: 12229244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced Molecular Detection of Malarone Resistance.
    Talundzic E; Plucinski MM; Biliya S; Silva-Flannery LM; Arguin PM; Halsey ES; Barnwell JW; Vannberg F; Udhayakumar V
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3821-3. PubMed ID: 27001821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of Cytochrome
    Lin JT; Waltmann A; Moser KA; Park Z; Na YB; Aydemir O; Brazeau NF; Gosi P; Marsh PW; Muller MS; Spring M; Sok S; Bailey JA; Saunders DL; Lon C; Wojnarski M
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmodium falciparum malaria and atovaquone-proguanil treatment failure.
    Durand R; Prendki V; Cailhol J; Hubert V; Ralaimazava P; Massias L; Bouchaud O; Le Bras J
    Emerg Infect Dis; 2008 Feb; 14(2):320-2. PubMed ID: 18258131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.
    Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children.
    Anabwani G; Canfield CJ; Hutchinson DB
    Pediatr Infect Dis J; 1999 May; 18(5):456-61. PubMed ID: 10353520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
    Forestier E; Labe A; Raffenot D; Lecomte C; Rogeaux O
    Med Mal Infect; 2011 Jan; 41(1):41-3. PubMed ID: 20800398
    [No Abstract]   [Full Text] [Related]  

  • 40. Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.
    Polhemus ME; Remich S; Ogutu B; Waitumbi J; Lievens M; Ballou WR; Heppner DG
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1493-5. PubMed ID: 18268090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.